The Institute for Chemical Epigenetics Munich (ICEM) with a usable area of 3,430 m2 and a funding amount of 38.73 million euros has received a funding recommendation in 2015 from the Wissenschaftsrat and had its roofing ceremony in 2019. The ICEM is based on the Cluster of Excellence Center for integrated Protein Science Munich (CIPSM) and the CRC 1309 and will explore the research focus of chemical epigenetics. The proposal was written by CIPSM speaker Thomas Carell and the managing director Oliver Baron.
ICEM was erected on the HighTech Campus Großhadern-Martinsried in the immediate vicinity of the BioSysM, the University of Munich Hospital and the Faculty of Chemistry and Pharmacy.
The ICEM aims after the planned move-in in 2021 to elucidate the functions of modified DNA and RNA bases in the cell to decrypt the chemical information level of the nucleic acids above the sequence information. The research building opens up a new field of research at the interface between chemistry and biology. The outstanding position of the campus in the life sciences is further strengthened by an internationally highly visible focus in chemical biology and epigenetics research.